Targeted protein degradation can be used to achieve efficacy in various disease contexts where other therapies fail. PROTACs® are unique, high-molecular-weight compounds that facilitate the labeling of a target protein, marking it for removal by cellular degradation machinery. These molecules bring two proteins together, and action dependent on the formation of a three-part complex introduces challenges during drug discovery and development.
Learn how to identify PROTAC candidates using DNA-encoded libraries and explore specialized screening and analytical techniques for target validation, compound optimization, mechanistic studies, and in vivo testing.
PROTAC® is a registered trademark of Arvinas Operations, Inc., and is used under license.
Copyright © 2024 American Chemical Society | 1155 Sixteenth Street NW | Washington, DC 20036 | View our Privacy Policy